Influenza Vaccine for Decision Making in Healthcare Providers
(IMPACT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a flu vaccine might affect the decision-making abilities of healthcare providers, such as doctors and nurse practitioners, when experiencing mild inflammation (a temporary body reaction). Participants will receive either the flu shot or a saline placebo (a harmless saltwater injection) and then answer questions and take tests to assess any changes in decision-making. It is ideal for emergency or internal medicine healthcare providers who have not received a flu shot this season and can attend two research sessions. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to important medical insights.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Past studies have commonly shown that healthcare workers use the flu vaccine. Research indicates that many healthcare workers receive the flu shot annually, with up to 94.6% of pharmacists and 92.6% of doctors getting vaccinated. The vaccine is generally well-tolerated, with common side effects including soreness at the injection site and mild fever. Serious side effects are rare. The vaccine has proven effective in lowering the chance of contracting the flu and helps reduce sick days from work. This suggests that the flu vaccine is a safe choice for most people.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it is exploring how the influenza vaccine can influence decision-making in healthcare providers. Unlike the typical focus on patient immune response, this study looks at the vaccine's potential broader impact on healthcare professionals' choices and actions, which is a unique angle. This could lead to a deeper understanding of how vaccines might indirectly affect healthcare delivery and outcomes.
What evidence suggests that this protocol is effective for influencing decision-making in healthcare providers?
Research shows that the seasonal flu vaccine effectively prevents the flu. In this trial, some participants will receive the influenza vaccine, while others will receive a placebo injection. Studies have found that when the vaccine matches the flu strains well, it can be up to 90% effective in healthcare workers. One study showed that fewer people experienced flu-like symptoms in the vaccinated group, with only 18% getting sick compared to 36% in those who weren't vaccinated. The flu vaccine also reduces the severity of the illness, lowering the chances of serious outcomes like needing intensive care or dying by 23%. These findings suggest that the flu vaccine effectively prevents the flu and reduces its severity.678910
Are You a Good Fit for This Trial?
This trial is for emergency medicine and internal medicine healthcare providers. Participants should be able to attend two lab sessions on consecutive days. There are no detailed inclusion or exclusion criteria listed.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend two lab sessions on consecutive days, receive either a seasonal influenza vaccine or a saline placebo, provide blood samples, and complete standardized assessments of medical decision-making and social attitudes.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Influenza vaccine
Trial Overview
The study tests whether getting a flu vaccine (which causes mild inflammation) affects how healthcare providers make decisions, compared to a placebo shot. It uses a randomized, double-blind design where all participants eventually receive the vaccine.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Receives the influenza vaccine at the end of Session 1
Receives a saline placebo injection at the end of Session 1
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arkansas, Fayetteville
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Collaborator
University of New Mexico
Collaborator
University of Arkansas
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Carilion Clinic
Collaborator
Loma Linda University
Collaborator
Citations
Survey of Adult Influenza Vaccination Practices and ... - PMC
Response rate was 67% (620/930). Ninety-eight percent always/almost always recommended influenza vaccine to adults ≥ 65 years, 90% for adults ...
Published Large U.S. Study Finds Comparable ...
There were 836 cases of PCR-confirmed influenza (3.9 per 1,000 persons) identified after adjuvanted vaccine and 867 cases (4.0 per 1,000 persons) ...
Effectiveness of seasonal influenza vaccination in ...
Although studies may provide contradictory conclusions, vaccine efficacy in HWs has been shown to be as high as 90% for well-matched seasonal influenza vaccines ...
Protective Impact of Influenza Vaccination on Healthcare ...
Results: The incidence of influenza-like illness was significantly lower in the vaccinated (18%) compared to the control group (36%; p = 0.046; OR = 0.39; 95% ...
Interim Effectiveness of the Influenza Vaccine for the 2024- ...
Results Among 53321 employees, 43771 (82.1%) had received the influenza vaccine by the end of the study. Influenza occurred in 324 (0.6%) during ...
6.
fda.gov
fda.gov/vaccines-blood-biologics/lot-release/importance-influenza-vaccination-health-care-personnelImportance of Influenza Vaccination for Health Care ...
One hospital evaluated the impact of vaccination on HCP and hospitalized patients and saw an increase in immunization coverage from 4% to 67% ...
Increasing influenza immunization rates among healthcare ...
Of the 102 respondents, nearly 30% reported within i.e. HCP) vaccinated for influenza each season.
Workplace Strategies May Improve Flu, COVID-19 Vaccine ...
Pharmacists (94.6%), physicians (92.6%), and HCP in hospital settings (88.3%) demonstrated the highest influenza vaccination coverage.
Mandatory Flu Vaccine for Healthcare Workers: Not Worthwhile
The relative risk reduction for influenza infection associated with influenza vaccine was 59%. However, the absolute risk reduction was only 1.4 ...
10.
cidrap.umn.edu
cidrap.umn.edu/influenza-vaccines/infection-control-group-emphasizes-health-worker-flu-vaccinationInfection control group emphasizes health worker flu vaccination
In a report on flu vaccine uptake among healthcare workers during the 2010-11 flu season, the CDC said 63.5% were immunized, a small increase ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.